Package 63824-540-69

{"route": ["ORAL"], "spl_id": "3b17bc33-de32-dd1b-e063-6294a90adb9d", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0363824014654"], "unii": ["9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1043543"], "spl_set_id": ["a25278bd-c3b9-4db3-b4f7-b395eb5f9177"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["RB Health (US) LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "180 mL in 1 BOTTLE (63824-540-66)", "package_ndc": "63824-540-66", "marketing_start_date": "20171101"}, {"sample": false, "description": "266 mL in 1 BOTTLE (63824-540-69)", "package_ndc": "63824-540-69", "marketing_start_date": "20171101"}], "brand_name": "Mucinex Fast-Max Severe Congestion and Cough", "product_id": "63824-540_3b17bc33-de32-dd1b-e063-6294a90adb9d", "dosage_form": "SOLUTION", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "63824-540", "generic_name": "dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride", "labeler_name": "RB Health (US) LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Mucinex Fast-Max", "brand_name_suffix": "Severe Congestion and Cough", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "20 mg/20mL"}, {"name": "GUAIFENESIN", "strength": "400 mg/20mL"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "10 mg/20mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20171101", "listing_expiration_date": "20261231"}